Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05455294
Title Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jacqueline Garcia, MD
Indications

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

chronic myelomonocytic leukemia

myelofibrosis

acute myeloid leukemia

Therapies

Decitabine + Navitoclax + Venetoclax

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.